A Study Evaluating Treatment Regimens Containing Vebicorvir (ABI-H0731) in Participants With Chronic Hepatitis B Infection
Trial details
- Registry ID
- NCT04820686
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as Vebicorvir, ABI-H0731
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study Evaluating Treatment Regimens Containing Vebicorvir (ABI-H0731) in Participants With Chronic Hepatitis B InfectionNCT04820686 | Assembly Biosciences | Phase 2 | Terminated | 2023-03-30Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |